Skip to content
★ Sign in to follow
IOL Chemicals and Pharmaceuticals Limited logo

IOL Chemicals and Pharmaceuticals Limited Stock: price and insider trades · India

IN·Mcap ₹47.9BHealth Care

No insider purchase over the last 90 days. The latest, by NCVI Enterprises Limited, was filed 20 Mar 2026.

IOL Chemicals and Pharmaceuticals Limited: what insiders have been doing

IOL Chemicals and Pharmaceuticals Limited is a Health Care company. Its directors and officers file their transactions with SEBI (PIT + SAST). In the past year (9 November 2025 to 9 November 2026), 5 filings came from 3 insiders.

No insider sold shares on the market over the period. Instead, the filings list 5 purchases totalling €1.7M, made by 3 insiders. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 3 major shareholders. NCVI Enterprises Limited filed the largest purchase, €482k, on 19 March 2026, which represents 0.11% of the company's market value.

Across the 1,985 companies tracked on its exchange, the median is 4 filings; at 5 filings, this issuer sits above that mark. Looking back to 2021, when coverage begins, insiders filed 5 purchases and 2 sales.

Within a 30-day window, 5 purchases overlapped with buying by a second insider. Purchases made close together by different insiders form what is called a cluster. The most recent open-market purchase was published on 20 March 2026, 234 days ago. Between a trade and the moment it shows up on SEBI (PIT + SAST), the median delay is 1 day. Until a filing is published, the market cannot know about the trade.

Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.

Insider Decl.
7
Thresholds
n/a
Buy Volume
€2M
5 ops. · all time
Sell Volume
€40,574
2 ops. · all time

Who traded when

BuySale
NCVI Enterprises Limited3 buys
Mayadevi Polycot Limited2 buys

Since the insiders bought

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 14,830 of 26,911 companies
48.5
score / 100
Value
37
Quality
61
FCF yld0.7%
Earn yld2.4%
EV/EBITDA21.3x
ROE7.9%
Gross mgn34%
Net mgn6.0%
Debt/EBITDA0.5x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹163.18
Analyst consensus
1 analysts
1.00/5
₹150.00Target ₹150.00(-8%)₹150.00
Income statement
Revenue₹23.2B
Gross profit₹8.3B36% margin
EBITDA₹2.8B12% margin
Net income₹1.4B5.9% margin
Valuation
PER (trailing)34.8x
PER (forward)20.1x
P/Book2.7x
Beta0.48
Balance sheet & cash
Market cap₹47.9B
Total debt₹1.4B
Free Cash Flow₹413.3M
Debt / Equity8%
Profitability & ownership
ROE7.9%
ROA4.7%
% insiders66.1%
% institutions1.3%
Last declaration on 20 March 2026
Declarations7 total
  • ▲
    Related company / holdingExecutives
    30M INR24SEBI
    404,305 shares@ ₹74.5580.066% mcap36.9% of flowEquity SharesSEBI:2d42ae11236b05cf57ec3bfaee04b80e49652f17
    Canonical exit: 17 Jun 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    51M INR26SEBI
    700,000 shares@ ₹73.44110.11% mcap63.1% of flowEquity SharesSEBI:853be90ccf3f42c7e6f9347b08247ca9cf2cdf94
    Canonical exit: 16 Jun 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    4M INR21SEBI
    54,197 shares@ ₹73.80870.0087% mcap8.2% of flowEquity SharesSEBI:97eaab46275191d593a51a9b8b9232146eb7b935
    Canonical exit: 16 Jun 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    45M INR25SEBI
    654,123 shares@ ₹68.36220.098% mcap91.8% of flowEquity SharesSEBI:4fe388d14b15fba56f32429b715ac83d07d9b861
    Canonical exit: 15 Jun 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    48M INR25SEBI
    700,000 shares@ ₹68.88710.11% mcap100.0% of flowEquity SharesSEBI:1f9f9591a0aa30341610bb92a8cc860bfe32b53f
    Canonical exit: 14 Jun 2026 (T+90)
  • ▼
    Executives
    1M INR6SEBI
    2,475 shares@ ₹567.1430.0038% mcap39.7% of flowEquity SharesSEBI:f310dcff85da33eb985411570a4b0f0542940f63
  • ▼
    Executives
    2M INR8SEBI
    3,525 shares@ ₹605.000.0057% mcap60.3% of flowEquity SharesSEBI:24c29fc8138ac83d804198abd052e32b112ed0b4

7 of 7 declarations

About IOL Chemicals and Pharmaceuticals Limited

IOL Chemicals and Pharmaceuticals Limited is an Indian company engaged in the manufacturing of chemicals and pharmaceuticals. It primarily operates on the Bombay Stock Exchange.